
|Articles|June 1, 2003
Unoprostone increases outflow facility to reduce IOP
Author(s)Chet Scerra
Fort Lauderdale, FL-An increase in outflow facility appears to be the mechanism by which unoprostone isopropyl ophthalmic solution (Rescula 0.15%, Novartis) reduces IOP, said Carol B. Toris, PhD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
2
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
3
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
4
Meta's AI glasses for veterans: Canto-Sims, OD on closing the access gap
5


























